Back to Search Start Over

Endoscopic ultrasound-guided choledochoduodenostomy with electrocautery-enhanced lumen-apposing stents: a retrospective analysis.

Authors :
Jacques J
Privat J
Pinard F
Fumex F
Valats JC
Chaoui A
Cholet F
Godard B
Grandval P
Legros R
Kerever S
Napoleon B
Source :
Endoscopy [Endoscopy] 2019 Jun; Vol. 51 (6), pp. 540-547. Date of Electronic Publication: 2018 Oct 22.
Publication Year :
2019

Abstract

Background: Endoscopic ultrasound-guided biliary drainage is an alternative to percutaneous biliary drainage in cases of malignant biliary obstruction and failure of classic endoscopic drainage by endoscopic retrograde cholangiopancreatography (ERCP). Recently, a new electrocautery-enhanced lumen-apposing metal stent (ECE-LAMS) that allows for endoscopic anastomosis (apposition stent) has become available for use in EUS-choledochoduodenostomy (EUS-CDS) and facilitates the procedure.<br />Methods: This was a retrospective study of all EUS-CDS procedures performed in France between April 2016 and August 2017. The primary end point was the technical and clinical success rates of EUS-CDS using an ECE-LAMS.<br />Results: 52 consecutive patients were included in the study. The etiology of distal bile duct obstruction was distal pancreatic adenocarcinoma in 43 patients (82.7 %). The technical success rate was 88.5 % (46 /52 patients), and the clinical success rate was 100 % (46/46 patients). The mean duration of the procedure was 10.2 minutes (range 1 - 90). Two patients (3.8 %) presented with short-term complications after EUS-CDS and before discharge from hospital. In univariate analyses, a small diameter of the common bile duct and not following the recommended procedure technique were significant risk factors for technical failure. Over a mean follow-up of 157 days, the median survival time without biliary complications was 135 days.<br />Conclusion: EUS-CDS with an ECE-LAMS is efficacious and safe in distal malignant obstruction of the common bile duct and could be proposed as the first option in cases of ERCP failure.<br />Competing Interests: Drs. Jacques, Privat, Fumex, Legros, and Napoleon are consultants for Boston Scientific.<br /> (© Georg Thieme Verlag KG Stuttgart · New York.)

Details

Language :
English
ISSN :
1438-8812
Volume :
51
Issue :
6
Database :
MEDLINE
Journal :
Endoscopy
Publication Type :
Academic Journal
Accession number :
30347424
Full Text :
https://doi.org/10.1055/a-0735-9137